Compare PAHC & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAHC | CIM |
|---|---|---|
| Founded | 1946 | 2007 |
| Country | United States | United States |
| Employees | N/A | 423 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2014 | N/A |
| Metric | PAHC | CIM |
|---|---|---|
| Price | $32.07 | $13.13 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $41.25 | $15.25 |
| AVG Volume (30 Days) | 250.7K | ★ 816.0K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | 0.91% | ★ 10.92% |
| EPS Growth | ★ 1883.33 | N/A |
| EPS | ★ 1.90 | N/A |
| Revenue | ★ $833,350,000.00 | N/A |
| Revenue This Year | $17.03 | $1.62 |
| Revenue Next Year | $3.82 | $2.48 |
| P/E Ratio | $17.04 | ★ N/A |
| Revenue Growth | ★ 4.12 | N/A |
| 52 Week Low | $25.58 | $11.67 |
| 52 Week High | $60.08 | $14.88 |
| Indicator | PAHC | CIM |
|---|---|---|
| Relative Strength Index (RSI) | 44.94 | 46.22 |
| Support Level | $30.46 | $13.05 |
| Resistance Level | $34.49 | $13.19 |
| Average True Range (ATR) | 1.22 | 0.26 |
| MACD | 0.46 | -0.03 |
| Stochastic Oscillator | 40.30 | 30.38 |
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Chimera Investment Corporation is an internally managed REIT whose principal business objective is to provide attractive risk-adjusted returns and distributable income through investment performance linked to mortgage credit fundamentals. Through its mortgage lending, investment management, and advisory services platforms, the Company operates as a fully integrated mortgage business that originates, manages, and invests in a diversified range of mortgage assets. The Company invests, directly or indirectly, generally on a levered basis across a spectrum of mortgage assets, including residential mortgage loans, Non-Agency RMBS, Agency RMBS, Agency CMBS, MSRs, business purpose and investor loans, including RTLs, and other real estate-related assets.